224 related articles for article (PubMed ID: 27259377)
1. Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment.
Rodrigues CF; Silva S; Azeredo J; Henriques M
Lett Appl Microbiol; 2016 Aug; 63(2):77-81. PubMed ID: 27259377
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.
Rodrigues CF; Gonçalves B; Rodrigues ME; Silva S; Azeredo J; Henriques M
Mycopathologia; 2017 Aug; 182(7-8):653-664. PubMed ID: 28439794
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of liposomal amphotericin B against four species of Candida biofilms in an experimental mouse model of intravascular catheter infection.
Fujimoto K; Takemoto K
J Infect Chemother; 2018 Dec; 24(12):958-964. PubMed ID: 30209024
[TBL] [Abstract][Full Text] [Related]
4. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition.
Rodrigues CF; Rodrigues ME; Henriques M
Biofouling; 2018 May; 34(5):569-578. PubMed ID: 29798695
[TBL] [Abstract][Full Text] [Related]
6. Role of major facilitator superfamily transporter Qdr2p in biofilm formation by Candida glabrata.
Widiasih Widiyanto T; Chen X; Iwatani S; Chibana H; Kajiwara S
Mycoses; 2019 Dec; 62(12):1154-1163. PubMed ID: 31519064
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
[TBL] [Abstract][Full Text] [Related]
8. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
Toulet D; Debarre C; Imbert C
J Antimicrob Chemother; 2012 Feb; 67(2):430-2. PubMed ID: 22081268
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model.
Basas J; Palau M; Gomis X; Almirante B; Gavaldà J
PLoS One; 2019; 14(2):e0212426. PubMed ID: 30779771
[TBL] [Abstract][Full Text] [Related]
10. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
11. Candida tropicalis biofilm's matrix--involvement on its resistance to amphotericin B.
Fernandes T; Silva S; Henriques M
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):165-9. PubMed ID: 26189843
[TBL] [Abstract][Full Text] [Related]
12. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of hypoxia and hypoxia mimetic cobalt chloride on in vitro adhesion, biofilm formation and susceptibility to amphotericin B of Candida glabrata.
Gupta P; Nath S; Meena RC; Kumar N
J Mycol Med; 2014 Dec; 24(4):e169-77. PubMed ID: 25442919
[TBL] [Abstract][Full Text] [Related]
14. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Samaranayake YH; Yau JY; Thein ZM; Jayatilake JA; Yeung KW; Samaranayake LP
Med Mycol; 2010 Aug; 48(5):725-34. PubMed ID: 20092419
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
[No Abstract] [Full Text] [Related]
16. The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata.
Rodrigues CF; Vilas Boas D; Haynes K; Henriques M
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30380780
[No Abstract] [Full Text] [Related]
17. Candida glabrata Biofilms: How Far Have We Come?
Rodrigues CF; Rodrigues ME; Silva S; Henriques M
J Fungi (Basel); 2017 Mar; 3(1):. PubMed ID: 29371530
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
19. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
20. Release of different amphotericin B formulations from PMMA bone cements and their activity against Candida biofilm.
Czuban M; Wulsten D; Wang L; Di Luca M; Trampuz A
Colloids Surf B Biointerfaces; 2019 Nov; 183():110406. PubMed ID: 31401462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
